Article metrics

Download PDFPDF
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial

 

Online download statistics by month:

Online download statistics by month: May 2024 to October 2024

AbstractFullPdf
May 20247742417
Jun 2024645107
Jul 202413383817
Aug 202418765
Sep 202412864
Oct 202426932
Total33418752